Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Dabrafenib 150 / Trametinib 2, Malignant Melanoma

Protocol-ID: 717 V1.1 (Mini), DABR150/TRAM2, Melanoma

Indication(s)

  • Melanoma, Malignant (BRAF V600E mutation); ICD-10 C44.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.06.2017